Ascent Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
Ascent Group's DXCM Position: Q2 2026 in Review
Ascent Group increased its DexCom (DXCM) stake by 3.9% in Q2 2026, buying an estimated $32.4K and bringing the position to 12,934 shares worth $871K. The position accounts for 0.03% of the portfolio, ranked #425.
Ascent Group first reported a position in DXCM in Q4 2021 and has held it in 19 quarters since. The position peaked at $896K in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Ascent Group held 12,934 shares of DexCom worth $871K as of Q2 2026.
- Ascent Group bought 487 DexCom shares in Q2 2026, an estimated $32.4K.
- DexCom made up 0.03% of Ascent Group's portfolio in Q2 2026, its #425 holding.
- Ascent Group first reported a position in DexCom in Q4 2021 and has held it in 19 quarters since.
- Ascent Group's DexCom position peaked at $896K in Q2 2025.
- 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.